New Book of Laboratory Medicine

What is it about?

- My Book written in Clinical Laboratory Medicine, “ Hematological and Metabolical Aspects from Laboratory Medicine” , confirm the aria of my interest in discovery of carcinogenesis mechanisms, especially in onco-haematology field, Leukemia. Seller www.amazon.com , www.alibris.com -Also, my new e-Book: e-BOOK: Hematological and Metabolical Aspects of Laboratory Medicine (Hematological and Metabolical Aspects from Laboratory Medicine) ( Second Edition ) [Large Print] [Paperback]. -Publisher: Aurelian Udristioiu, 2 edition (September 9, 2013) Full Color on White paper, 122 pages. ISBN-13: 978-1492186816 (CreateSpace-Assigned) ISBN-10: 1492186813, BISAC: Medical / Laboratory Medicine, USA. Sold by www.amazon.com -Please, see the Blog of my Medical Book : http://aurelianudristioiu.blogspot.com aurelian-udristioiu.strikingly.com medicallaboratorybooks.yolasite.com/ Thanks.~! - Aurelian Udristioiu, M.D, - Lab Director, EuSpLM, - City Targu Jiu, Romania - Member of National Academy of Biochemical Chemistry (NACB) , Washington D.C, USA. -Fellow PhD, Molecular Biology, Titu Maiorescu University, General Medicine Faculty, Bucharest, Romania, -Man of Medical Year/2015, Certificate International Biographic Center, IBC, Cambridge, UK.

Featured Image

Photo by JC Gellidon on Unsplash

Photo by JC Gellidon on Unsplash

Why is it important?

The medical book, "Hematological and Metabolical Aspects of Laboratory Medicine", 3-nd edition, continues the analysis of hematologic and metabolic aspects of the 3-nd edition, in the context of international fundamental research. The volume is again successful Romanian medical school in abroad, and through this book brings a substantial contribution of Romanian medicine to universal medicine. It is not possible in this review, limited inevitably to be analyzed numerous data presented in the 15 chapters, but we emphasize the following: - "Energy levels of the metabolic pathways in malignant B and T lymphocytes in Review" ,the chapter presents the latest evidence from the literature on cellular metabolites that may be oncogenic by modifying cell signaling and blocking cellular differentiation. Advances in cancer metabolism research in the last decade have increased our understanding on aerobic glycolysis, anaerobic and other metabolic changes that are associated with cell growth and proliferation. Blocking apoptosis in malignant diseases may be due to the high concentration of ATP from anaerobic metabolism. Energy difference between anaerobic ATP B and T lymphocytes in peripheral blood samples from hematopoietic malignancies measured by bioluminescence was 2.68 μM ATP, a value that appears as an energy transfer between normal B cells and T cells. The energy level can initiate the process of carcinogenesis by suppressing the activity of anti-oncogene proteins. It is concluded that anabolic metabolism in B and T cells in hematological malignancies are under complex regulatory control, directed by receptors on the cell membrane associated with an increase in signal transduction in cells transformed into malignancy. -The research paper " Endogenous effects of alcohol on liver function " it sends a signal to the population as grim statistics that mortality from alcoholic liver disease in recent years has been higher than the of several major forms of cancer such as breast, colon and prostate . An international AASLD / ACG 2010 national guidance on the treatment of severe alcoholic hepatitis is proposed to be necessary in all treatment centers for liver disease due to chronic alcoholism. -In the chapter "Drugs -induced hemolytic anemia " is presented a case that the best illustrates the cases of laboratory with drug-induced hemolytic anemia ( DIHA ) which are rarely discovered, and for this a specialized laboratory is often required to be performed with optimal serological tests to confirm the diagnosis. Some of the mechanisms involved in DIHA are controversially. Unfortunately, most drugs that cause severe intravascular hemolysis, anemia, renal failure, disseminated intravascular coagulation times and even death, may have different mechanisms and typically involves drug addiction drug antibodies that trigger activity in serum total complement became the context of autoimmune hemolytic anemia.

Perspectives